论文部分内容阅读
目的探讨氯诺昔康和杜冷丁治疗输尿管结石肾绞痛疗效。方法 2008年2月至2010年3月收治的输尿管结石肾绞痛患者160例,依据治疗方法分为杜冷丁组80例、氯诺昔康组80例,观察两组临床疗效及不良反应发生率。结果两组显效率、有效率比较P>0.05差异无统计学意义。两组不良反应发生率比较P<0.05差异有统计学意义。结论在输尿管结石肾绞痛治疗中应用氯诺昔康进行止痛,具有镇痛效果良好,不良反应发生率低,患者顺应性良好,可以作为杜冷丁的替代药用于输尿管结石肾绞痛。
Objective To investigate the efficacy of lornoxicam and dolantin in the treatment of ureteral calculi and renal colic. Methods 160 patients with ureteral calculus and renal colic who were admitted from February 2008 to March 2010 were divided into 80 cases of dolantin group and 80 cases of lornoxicam group according to the treatment method. The clinical efficacy and the incidence of adverse reactions . Results The two groups were markedly effective, effective rate was no significant difference P> 0.05. The incidence of adverse reactions between the two groups P <0.05 difference was statistically significant. Conclusions The application of lornoxicam to analgesic ureteral calculi in renal calculus has good analgesic effect, low incidence of adverse reactions and good compliance. It can be used as a substitute for dolantin for ureteral calculi and renal colic.